Europe Anatomic Pathology Market Report (2021-2031) by Scope, Segmentation, Dynamics, and Competitive Analysis

The anatomic pathology market size is expected to reach US$ 14,999.93 million by 2031 from US$ 8,461.65 million in 2023. The market is estimated to record a CAGR of 7.4% from 2023 to 2031.

Executive Summary and Europe Anatomic Pathology Market Analysis:

The anatomic pathology market in Europe is segmented into Germany, France, the UK, Italy, Spain, and the Rest of Europe. The market growth in the region is driven by the rising prevalence of cancer, including cervical and breast cancer. Moreover, the cancer screening initiatives undertaken by the health authorities in the region to reduce the incidence of chronic conditions are anticipated to offer growth opportunities for the market in the coming years.

Europe Anatomic Pathology Market Strategic Insights

Get more information on this report Request Free Sample PDF

Europe Anatomic Pathology Market Segmentation Analysis

Key segments that contributed to the derivation of the anatomic pathology market analysis are product and services, application, and end user.

• Based on product and services, the Europe anatomic pathology market is segmented into services, instruments, and consumables. The instruments held the largest share of the market in 2023. The services segment is further sub segmented into histopathology and cytopathology. The instruments segment is further sub segmented into microtomes and cryostat, automatic stainer's, tissue processors, and others.
• By application, the Europe anatomic pathology market is segmented into disease diagnosis, drug discovery and development, and others. The disease diagnosis segment held the largest share of the market in 2023.
• By end user, the Europe anatomic pathology market is segmented into hospitals, research laboratories, diagnostic laboratories, and others. The hospitals segment held the largest share of the market in 2023.

Europe Anatomic Pathology Market Outlook

Anatomic pathology is useful in identifying abnormalities that can help diagnose diseases, such as autoimmune diseases, kidney and liver diseases, and cancer. Histopathology, which involves studying tissue changes caused by diseases, is a vital part of anatomic pathology. Cancer has a major impact on society across the world. The burden of cancer on healthcare systems is significantly increasing worldwide as it is among the leading causes of death. The World Health Organization (WHO) ranks cancer as the second-leading cause of mortality worldwide. According to data published by the World Cancer Research Fund International, ~20 million new cases of cancer were registered in 2022 globally. Moreover, as per the data published by the World Health Organization (WHO), nearly 10 million deaths worldwide were caused by cancer in 2020. According to data published by Macmillan Cancer Support, ~392,000 people in the UK are diagnosed with cancer every year, while ~167,000 people die due to the disease each year.

The prevalence of chronic kidney disease is growing due to the increase in the geriatric population. Biopsy, an anatomic pathology technique, is used for the detection of cancer and chronic kidney disease. Owing to the increasing prevalence of cancer and kidney disease, government agencies, healthcare providers, and institutions are being compelled to contribute toward disease diagnosis and treatment initiatives. Thus, a surge in the prevalence of cancer and other targeted diseases such as autoimmune diseases, and kidney and liver diseases is driving the Europe anatomic pathology market growth.

Europe Anatomic Pathology Market Country Insights

Based on country, the Europe anatomic pathology market comprises the UK, Germany, France, Italy, Spain, and the Rest of Europe. Germany held the largest share in 2023.

Cytology has gained significant recognition in Germany, even among nonmedical individuals, due to mass screening programs for cervical cancer. The government of Germany is making efforts to improve its medical infrastructure for people. As per an article published in PubMed Central in August 2022, the cervical cancer screening program for women aged 35 and older in the Statutory Health Insurance (GKV) in Germany was modified on January 1, 2020. As per the revised guidelines, women now undergo cytological and human papillomavirus (HPV) co-testing every 3 years instead of an annual cytology examination. MVZ for cytology and molecular biology, a major diagnostics laboratory has been using liquid-based cytology (LBC) with computer-assisted screening (CAS) since January 1, 2020, to analyze the samples.

The rising prevalence of cervical cancer cases has led to an increase in cervical cancer screenings in laboratories across the country. According to an article published in the European Journal of Cancer in April 2024, cytology remains an essential part of cervical cancer screening, and the mass primary high-risk HPV screening followed by triaging may aid in the elimination of cervical cancer in the future. The study was carried out to investigate the accuracy of routine smear assessment in Germany. The researchers audited 1,632 routine smears retrieved from 97 laboratories across the country. Additionally, the presence of renowned research institutions contributes to the development of advanced pathology tests for early disease diagnosis and prevention. The Institute for Pathology, Cologne, offers a demanding routine Anatomical Pathology Service, handling about 40,000 surgical specimens and 20,000 consultations annually, along with conducting 150 postmortems each year. Thus, the rising number of pathological screening programs and the presence of pathology labs across the country drive the anatomic pathology market in Germany.

Europe Anatomic Pathology Market Report Highlights

Europe Anatomic Pathology Market Company Profiles

Some of the key players operating in the market include F. Hoffmann-La Roche Ltd, Beckman Coulter Inc, Hologic Inc, Agilent Technologies Inc, Diapath S.p.A., Bio SB, Merck KGaA, and PHC Holdings Corporation among others. These players are adopting various strategies such as expansion, product innovation, and mergers and acquisitions to provide innovative products to their consumers and increase their market share.

Europe Anatomic Pathology Market Research Methodology :

The following methodology has been followed for the collection and analysis of data presented in this report:

• Secondary Research

The research process begins with comprehensive secondary research, utilizing both internal and external sources to gather qualitative and quantitative data for each market. Commonly referenced secondary research sources include, but are not limited to:

• Company websites, annual reports, financial statements, broker analyses, and investor presentations.
• Industry trade journals and other relevant publications.
• Government documents, statistical databases, and market reports.
• News articles, press releases, and webcasts specific to companies operating in the market.

Note: All financial data included in the Company Profiles section has been standardized to USD. For companies reporting in other currencies, figures have been converted to USD using the relevant exchange rates for the corresponding year.

• Primary Research

The Insight Partners’ conducts a significant number of primary interviews each year with industry stakeholders and experts to validate its data analysis, and gain valuable insights. These research interviews are designed to:

• Validate and refine findings from secondary research.
• Enhance the expertise and market understanding of the analysis team.
• Gain insights into market size, trends, growth patterns, competitive dynamics, and future prospects.

Primary research is conducted via email interactions and telephone interviews, encompassing various markets, categories, segments, and sub-segments across different regions. Participants typically include:

• Industry stakeholders: Vice Presidents, business development managers, market intelligence managers, and national sales managers
• External experts: Valuation specialists, research analysts, and key opinion leaders with industry-specific expertise

Europe Anatomic Pathology Market Country and Regional Insights